{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:08:21Z","timestamp":1764936501525},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.diabres.2008.09.012","type":"journal-article","created":{"date-parts":[[2008,10,27]],"date-time":"2008-10-27T08:05:10Z","timestamp":1225094710000},"page":"S25-S29","source":"Crossref","is-referenced-by-count":18,"special_numbering":"S1","title":["Inhibition of advanced glycation end products (AGEs): An implicit goal in clinical medicine for the treatment of diabetic nephropathy?"],"prefix":"10.1016","volume":"82","author":[{"given":"Toshio","family":"Miyata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Dan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2008.09.012_bib1","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/01.ASN.0000062961.76776.C1","article-title":"Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model","volume":"14","author":"Nangaku","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2008.09.012_bib2","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1093\/ndt\/gfi096","article-title":"In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative\/carbonyl stress and prevents diabetic nephropathy","volume":"20","author":"Nangaku","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2008.09.012_bib3","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1681\/ASN.2005050522","article-title":"Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering","volume":"16","author":"Izuhara","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2008.09.012_bib4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1523-1755.2005.00145.x","article-title":"Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications","volume":"67","author":"Wolf","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.diabres.2008.09.012_bib5","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1172\/JCI2450","article-title":"A mesangium-predominant gene, megsin, is a new serpin up-regulated in IgA nephropathy","volume":"102","author":"Miyata","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2008.09.012_bib6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1172\/JCI0214336","article-title":"Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion","volume":"109","author":"Miyata","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2008.09.012_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2337\/diabetes.55.02.06.db05-0702","article-title":"A severe diabetic nephropathy model with early development of nodular-like lesions induced by megsin overexpression in RAGE\/iNOS transgenic mice","volume":"55","author":"Inagi","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2008.09.012_bib8","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1001\/jama.290.16.2159","article-title":"Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy","volume":"290","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2008.09.012_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000093632","article-title":"Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications","volume":"26","author":"Sarafidis","year":"2006","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.diabres.2008.09.012_bib10","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.2337\/diabetes.54.7.2206","article-title":"Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients","volume":"54","author":"Pistrosch","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2008.09.012_bib11","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/sj.ki.5002570","article-title":"Thiazolidinediones protects the kidney better than insulin in an obese, hypertensive type 2 diabetes rat model","volume":"72","author":"Ohtomo","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.diabres.2008.09.012_bib12","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/ndt\/gfm715","article-title":"Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model","volume":"23","author":"Ohtomo","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2008.09.012_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1681\/ASN.2005070757","article-title":"Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure","volume":"17","author":"Nangaku","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.diabres.2008.09.012_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrm1366","article-title":"Oxygen sensing by HIF hydroxylases","volume":"5","author":"Schofield","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.diabres.2008.09.012_bib15","doi-asserted-by":"crossref","first-page":"40337","DOI":"10.1074\/jbc.M403057200","article-title":"Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress","volume":"279","author":"Salnikow","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.diabres.2008.09.012_bib16","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1097\/01.ASN.0000032418.67267.F2","article-title":"Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms","volume":"13","author":"Miyata","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.diabres.2008.09.012_bib17","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.2337\/diabetes.51.11.3274","article-title":"Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy","volume":"51","author":"Forbes","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2008.09.012_bib18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.amjcard.2004.05.007","article-title":"Effects of edaravone on reperfusion injury in patients with acute myocardial infarction","volume":"94","author":"Tsujita","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.diabres.2008.09.012_bib19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/ndt\/gfm601","article-title":"A novel class of advanced glycation inhibitors ameliorates renal and cardiovascular damage in experimental rat models","volume":"23","author":"Izuhara","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2008.09.012_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainres.2007.07.006","article-title":"A novel inhibitor of advanced glycation and endoplasmic reticulum stress reduces infarct volume in rat focal cerebral ischemia","volume":"1183","author":"Takizawa","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.diabres.2008.09.012_bib21","first-page":"1140","article-title":"LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats","volume":"46","author":"Figarola","year":"2006","journal-title":"Diabetologia"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822708004361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822708004361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T22:22:33Z","timestamp":1545690153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822708004361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":21,"alternative-id":["S0168822708004361"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2008.09.012","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}